Tag: Abiraterone Acetate
Addition of abiraterone to ADT/docetaxel does not increase bone loss

Both men with high-risk non-metastatic prostate cancer and men with metastatic prostate cancer benefit from intensified hormone treatment

Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC
